DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company, announced that President and CEO Rick Pauls will participate in the 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022, in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Investors and attendees that would like to schedule a meeting with DiaMedica’s management can contact their Craig-Hallum representative to arrange a meeting.
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20221107005660/en/
Chief Financial Officer
Phone: (763) 496-5118
skellen@diamedica.com
Corporate Communications
Phone: 617-899-5941
ppapi@diamedica.com
Source: